OCULOMUCOCUTANEOUS SYNDROME

OCULOMUCOCUTANEOUS SYNDROME was reported 425 times

OCULOMUCOCUTANEOUS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Neuraminidase Inhibitor [EPC] 3 0.0012
1 Plasma Volume Expander [EPC] 2 0.0006
2 Catechol-O-Methyltransferase Inhibitor [EPC] 2 0.0004
3 Mood Stabilizer [EPC] 71 0.0003
4 Anti-epileptic Agent [EPC] 54 0.0002
5 Paramagnetic Contrast Agent [EPC] 1 0.0002
6 Macrolide Antimicrobial [EPC] 9 0.0002
7 Aminosalicylate [EPC] 17 0.0002
8 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
9 Radiographic Contrast Agent [EPC] 4 0.0002
10 Stimulant Laxative [EPC] 2 0.0001
11 Dopamine-2 Receptor Antagonist [EPC] 1 0.0001
12 Glinide [EPC] 1 0.0001
13 Insulin [EPC] 5 0.0001
14 Leukotriene Receptor Antagonist [EPC] 3 0.0001
15 Antimalarial [EPC] 1 0.0001
16 Antiprotozoal [EPC] 1 0.0001
17 Programmed Death Receptor-1 Blocking Antibody [EPC] 9 0.0001
18 Epidermal Growth Factor Receptor Antagonist [EPC] 4 0.0001
19 Bile Acid Sequestrant [EPC] 1 0.0001
20 Melatonin Receptor Agonist [EPC] 1 0.0001
21 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
22 Histamine-2 Receptor Antagonist [EPC] 7 0.0001
23 Glycopeptide Antibacterial [EPC] 3 0.0000
24 Bile Acid [EPC] 1 0.0000
25 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
26 Loop Diuretic [EPC] 18 0.0000
27 Fluoroquinolone Antibacterial [EPC] 5 0.0000
28 Aromatase Inhibitor [EPC] 4 0.0000
29 Xanthine Oxidase Inhibitor [EPC] 6 0.0000
30 Angiotensin Converting Enzyme Inhibitor [EPC] 4 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 9 0.0000
32 Proton Pump Inhibitor [EPC] 15 0.0000
33 Atypical Antipsychotic [EPC] 11 0.0000
34 Sulfonylurea [EPC] 3 0.0000
35 General Anesthetic [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 29 0.0000
37 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
38 Angiotensin 2 Receptor Blocker [EPC] 7 0.0000
39 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
40 Platelet Aggregation Inhibitor [EPC] 12 0.0000
41 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
42 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
43 Purine Antimetabolite [EPC] 2 0.0000
44 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
45 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
46 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
47 Platinum-based Drug [EPC] 4 0.0000
48 Cardiac Glycoside [EPC] 1 0.0000
49 HER2/neu Receptor Antagonist [EPC] 1 0.0000
50 beta-Adrenergic Blocker [EPC] 4 0.0000
51 Non-Standardized Chemical Allergen [EPC] 1 0.0000
52 Arteriolar Vasodilator [EPC] 1 0.0000
53 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
54 Microtubule Inhibitor [EPC] 2 0.0000
55 Benzodiazepine [EPC] 8 0.0000
56 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
57 Corticosteroid [EPC] 13 0.0000
58 Antirheumatic Agent [EPC] 1 0.0000
59 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
60 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
61 Parathyroid Hormone Analog [EPC] 1 0.0000
62 Proteasome Inhibitor [EPC] 1 0.0000
63 alpha-Adrenergic Blocker [EPC] 1 0.0000
64 Aldosterone Antagonist [EPC] 1 0.0000
65 Azole Antifungal [EPC] 1 0.0000
66 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
67 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
68 RANK Ligand Inhibitor [EPC] 1 0.0000
69 Kinase Inhibitor [EPC] 2 0.0000